1. Home
  2. CBAT vs DXR Comparison

CBAT vs DXR Comparison

Compare CBAT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

HOLD

Current Price

$1.01

Market Cap

70.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$10.84

Market Cap

59.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBAT
DXR
Founded
1999
1970
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
59.0M
IPO Year
2025
1995

Fundamental Metrics

Financial Performance
Metric
CBAT
DXR
Price
$1.01
$10.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
511.2K
9.4K
Earning Date
05-18-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,446,345.00
Revenue This Year
$66.88
$44,935.22
Revenue Next Year
$41.54
$74.79
P/E Ratio
N/A
$33.83
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$8.56
52 Week High
$1.24
$14.76

Technical Indicators

Market Signals
Indicator
CBAT
DXR
Relative Strength Index (RSI) 64.28 57.42
Support Level $0.76 $9.26
Resistance Level $1.07 $10.99
Average True Range (ATR) 0.08 0.56
MACD -0.00 0.08
Stochastic Oscillator 68.46 80.47

Price Performance

Historical Comparison
CBAT
DXR

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments; CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe, India, Africa, and other regions.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.

Share on Social Networks: